[1] Ma LY, Chen WW, Gao RL, et al. China cardiovascular diseases report 2018: an updated summary. J Geriatr Cardiol, 2020; 17, 1−8.
[2] Springer J, Springer JI, Anker SD. Muscle wasting and sarcopenia in heart failure and beyond: update 2017. ESC Heart Fail, 2017; 4, 492−8. doi:  10.1002/ehf2.12237
[3] Lourenço P, Silva S, Friões F, et al. Low prealbumin is strongly associated with adverse outcome in heart failure. Heart, 2014; 100, 1780−5. doi:  10.1136/heartjnl-2014-305747
[4] Ingenbleek Y, Young V. Transthyretin (prealbumin) in health and disease: nutritional implications. Annu Rev Nutr, 1994; 14, 495−533. doi:  10.1146/annurev.nu.14.070194.002431
[5] Aimo A, Januzzi Jr JL, Mueller C, et al. Admission high-sensitivity troponin T and NT-proBNP for outcome prediction in acute heart failure. Int J Cardiol, 2019; 293, 137−42. doi:  10.1016/j.ijcard.2019.06.005
[6] Savarese G, Dahlström U, Vasko P, et al. Association between renin-angiotensin system inhibitor use and mortality/morbidity in elderly patients with heart failure with reduced ejection fraction: a prospective propensity score-matched cohort study. Eur Heart J, 2018; 39, 4257−65. doi:  10.1093/eurheartj/ehy621
[7] McKee PA, Castelli WP, McNamara PM, et al. The natural history of congestive heart failure: the Framingham study. N Engl J Med, 1971; 285, 1441−6. 
 doi:  10.1056/NEJM197112232852601
[8] Saitoh M, Dos Santos MR, Emami A, et al. Anorexia, functional capacity, and clinical outcome in patients with chronic heart failure: results from the Studies Investigating Co-morbidities Aggravating Heart Failure (SICA-HF). ESC Heart Fail, 2017; 4, 448−57. doi:  10.1002/ehf2.12209
[9] Nishi I, Seo Y, Hamada-Harimura Y, et al. Geriatric nutritional risk index predicts all-cause deaths in heart failure with preserved ejection fraction. ESC Heart Fail, 2019; 6, 396−405. doi:  10.1002/ehf2.12405
[10] Zoair AM, Abdel-Hafez MA, Mawlana W, et al. Serum levels of N- terminal-pro B-type natriuretic peptide as a diagnostic marker for left ventricular dysfunction in children with end-stage renal disease on hemodialysis. Saudi J Kidney Dis Transpl, 2016; 27, 1114−22. doi:  10.4103/1319-2442.194593